Skip to content

Human Ovarian Autotransplantation

Human Ovarian Autotransplantation Using Cryopreserved Ovarian Tissue in Women Treated for Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01403675
Enrollment
1
Registered
2011-07-27
Start date
2009-05-31
Completion date
2014-03-31
Last updated
2014-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Autotransplantation Using Cryopreserved Ovarian Tissue in Women Treated for Cancer

Keywords

women with cancer whose ovarian tissue has been collected and stored in liquid nitrogen before cancer therapy (surgery, chemotherapy, radiotherapy),, who are in remission (no recurrence of disease for 5 years),, who are in normal organ function and have no contraindication for surgery or pregnancy, and, who wish to restore ovarian function using stored ovarian tissue.

Brief summary

Chemotherapy can cause permanent damage to a woman's ovaries. Women who are cancer survivors may find that they are not able to produce female hormones, and they may not be able to have a child. Scientists are trying to find ways to help cancer survivors regain their hormonal function and possibly get pregnant, if they desire. Scientists have developed a method where ovarian tissue is removed and frozen before chemotherapy; then it is thawed and put back into the woman's body after she is cancer-free. Putting a woman's previously-frozen tissue back into her body is called ovarian autotransplantation. Ovarian autotransplantation is a very new technique, and there have only been a small number of women who have had this procedure. So far, only five babies in the world have been born using this technique. The purpose of this study is to learn more about ovarian autotransplantation. Scientists hope to find better ways to use this method to help a woman's ovaries start working again after chemotherapy. If the ovaries start working again, it might be possible to have a baby.

Interventions

PROCEDUREOvarian autotransplantation

There are two ways to transplant the thawed ovarian tissue back into a woman's body. It can be put back inside the abdomen, close to the natural location of the ovaries, or the tissue can be put under the skin of the abdomen. After you have had the transplant, your hormone function will be tested every month. Each month, you will have a blood draw to measure hormones and an ultrasound to see how the tissue is growing. These monthly visits will continue until you have normal hormone levels. If the transplant is successful, it is expected that your hormones would return to normal in 3 - 7 months. If your hormone levels return and stay regular for three months, then Dr. Kim will talk to you about trying to get pregnant. The method of getting pregnant will depend on the type of transplantation surgery you had and your current medical condition. You will have weekly blood tests and other tests to determine the best way to get pregnant.

Sponsors

Samuel Kim, MD
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Adult women (age between 18 and 40) who stored the ovary before cancer therapy. * Adult women who completed cancer therapy and are in remission. * Adult women who desire to conceive and are ready to have a baby.

Exclusion criteria

* Age under 18 or over 40 years old * Women with a disease at high risk for ovarian metastasis (such as leukemia) * Women with contraindication for surgery * Women with contraindication for pregnancy * Psychological instability to sustain pregnancy (diagnosed by a psychiatrist) * Women who are HIV Positive

Design outcomes

Primary

MeasureTime frameDescription
Comparision of orthotopic and heterotopic autotransplantation2009-2015The main purpose of this study is to investigate restoration of ovarian function and fertility by autotransplantation of human ovarian tissue using heterotopic and orthotopic techniques

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026